Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shogo Hiraoka"'
Autor:
Hiroyuki Tahara, Tatsumi Shiraishi, Eidai Tamura, John Mack, Kota Muramatsu, Tetsuo Okujima, Shogo Hiraoka, Masayoshi Takase, Shigeki Mori, Nagao Kobayashi, Hidemitsu Uno, Mako Hirose
Publikováno v:
Chemistry (Weinheim an der Bergstrasse, Germany). 26(25)
A bicyclo[2.2.2]octadiene(BCOD)-fused bis(dipyrromethane) derivative was reacted with methylal in the presence of trifluoroacetic acid followed by oxidation with chloranil to give a doubly N-confused phlorin derivative, which did not undergo the retr
Autor:
Hidemitsu Uno, Tetsuo Okujima, Takahiro Nakae, Shogo Hiraoka, Takayuki Honda, Manami Kitatsuka, Masayoshi Takase, Shigeki Mori
Publikováno v:
RSC Advances. 8:14072-14083
Benzene-fused bis(acenaphthoBODIPY)s prepared by retro-Diels–Alder reaction of bicyclo[2.2.2]octadiene-fused precursors showed strong absorption bands in the near-infrared region and very weak absorptions in the visible region.
Autor:
Masayoshi Takase, Tetsuo Okujima, Hidemitsu Uno, Takahiro Nakae, Hiroyuki Tahara, Shogo Hiraoka, Shigeki Mori
Publikováno v:
Tetrahedron. 73:957-963
Parikh–Doering oxidation of diethyl 9-hydroxy-2,6-dimethyl-4,8-dihydro-4,8-methanopyrrol[3,4-f]isoindole-1,7-dicarboxylate produced diethyl 9-oxo-2,6-dimethyl-4,8-dihydro-4,8-methanopyrrol[3,4-f]isoindole-1,7-dicarboxylate. This carbonyl derivative
Publikováno v:
Biologicalpharmaceutical bulletin. 40(5)
A 2% commercially available, milky-white, rebamipide micro-particle suspension is used to treat dry eyes, and it causes short-term blurring of the patient's vision. In the current study, to improve the transparency of a rebamipide suspension, we atte
Publikováno v:
Chemicalpharmaceutical bulletin. 63(5)
About half of patients with schizophrenia have poor adherence to taking medication, so many have recurrence, therefore, providing formulations that enable patients to continue their medication without interruption is important. We aimed to develop a
Publikováno v:
Chemicalpharmaceutical bulletin. 62(7)
The aim of this study was to obtain injectable high-drug-loading core-shell structure microspheres that release aripiprazole over 2 months. The microparticles were prepared by the oil-in-water emulsion solvent evaporation method and characterized. Th